CINECA IRIS Institutional Research Information System

MARCHI, SANTINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.264
EU - Europa 8.719
AS - Asia 2.649
AF - Africa 228
SA - Sud America 47
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 8
Totale 28.961
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.713
IT - Italia 3.511
CN - Cina 1.591
SE - Svezia 1.462
BG - Bulgaria 866
UA - Ucraina 667
DE - Germania 650
CA - Canada 541
GB - Regno Unito 465
VN - Vietnam 387
FI - Finlandia 327
CH - Svizzera 299
TR - Turchia 252
SG - Singapore 195
CI - Costa d'Avorio 133
AT - Austria 110
RU - Federazione Russa 97
HK - Hong Kong 95
FR - Francia 86
IN - India 58
BE - Belgio 47
NG - Nigeria 43
AU - Australia 38
SN - Senegal 36
NL - Olanda 30
ES - Italia 19
PL - Polonia 19
EC - Ecuador 13
KR - Corea 13
HU - Ungheria 12
JP - Giappone 12
NO - Norvegia 11
BR - Brasile 10
EG - Egitto 10
MX - Messico 10
GR - Grecia 8
IR - Iran 8
NZ - Nuova Zelanda 8
AR - Argentina 7
CL - Cile 7
CO - Colombia 7
EU - Europa 7
IE - Irlanda 7
IL - Israele 7
DK - Danimarca 6
CZ - Repubblica Ceca 5
ID - Indonesia 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
MY - Malesia 3
PE - Perù 3
PH - Filippine 3
RS - Serbia 3
BN - Brunei Darussalam 2
DZ - Algeria 2
ET - Etiopia 2
KZ - Kazakistan 2
RO - Romania 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
A1 - Anonimo 1
AL - Albania 1
AZ - Azerbaigian 1
EE - Estonia 1
HR - Croazia 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
ME - Montenegro 1
PK - Pakistan 1
SC - Seychelles 1
SI - Slovenia 1
TH - Thailandia 1
Totale 28.961
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.322
Ann Arbor 2.132
Houston 1.673
Chandler 1.488
Fairfield 1.392
Serra 1.199
Jacksonville 918
Milan 877
Sofia 866
Ashburn 729
Seattle 608
Beijing 582
Wilmington 528
New York 516
Cambridge 513
Ottawa 511
Princeton 380
Lawrence 344
Nanjing 333
Medford 316
Bern 293
Des Moines 267
Izmir 244
Dearborn 194
Jüchen 168
Dong Ket 154
Abidjan 133
Nanchang 131
London 120
Boulder 119
Vienna 103
Redwood City 97
Florence 87
Hong Kong 85
Kunming 83
San Diego 83
Pisa 60
Hebei 58
Changsha 54
Shenyang 54
Rome 53
Tianjin 53
Brussels 44
Lagos 43
Washington 42
Dakar 36
Hefei 33
Jiaxing 33
Bremen 32
Falls Church 32
Norwalk 31
Ogden 30
Verona 30
Los Angeles 28
Orange 28
Pune 26
Lancaster 24
Lanzhou 22
Auburn Hills 21
Guangzhou 20
Livorno 19
Phoenix 19
Jinan 18
Hangzhou 16
Boardman 15
Lucca 15
Shanghai 15
Toronto 15
Redmond 14
Amsterdam 13
Massa 13
Alessandria 12
Frankfurt am Main 12
San Francisco 12
Chicago 11
Southend 11
Sydney 11
Changchun 10
Groningen 10
Nürnberg 10
Chengdu 9
Council Bluffs 9
Düsseldorf 9
Pécs 9
Empoli 8
Cairo 7
Indiana 7
Mountain View 7
Xian 7
Bergen 6
Detroit 6
Dublin 6
Fuzhou 6
Grafing 6
Helsinki 6
Melbourne 6
Warsaw 6
Wuhan 6
Ypsilanti 6
Buenos Aires 5
Totale 21.883
Salva come PNG Salva come JPEG
Nome #
Evaluation of Pancreatic Exocrine Function in Patients With Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas 270
Serum gamma-glutamyltransferase fractions in myotonic dystrophy type I: differences with healthy subjects and patients with liver disease 214
Management of Chronic constipation in general practice 178
Symptom analysis improves GERD diagnosis and may be helpful to define a successful surgical approach 162
Differential diagnosis between functional and organic intestinal disorders: is there a role for non-invasive tests? 160
Symptom patterns can distinguish diverticular disease from irritable bowel syndrome. 159
Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett’s oesophagus for 1 year 155
Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics 153
Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study 153
Esophageal chemical clearance and baseline impedance values in patients with chronic autoimmune atrophic gastritis and gastro-esophageal reflux disease 150
Lactobacillus Casei DG® in Patients with Irritable Bowel Syndrome: Not Only a Change of the Gut Microbiota. A Pilot Study 141
Not all anti-reflux treatment failures are due to persistence of abnormal esophageal acid exposure 139
Role of faecal calprotectin as non-invasive marker of intestinal inflammation 139
Gastric mucosal distribution and clinical efficacy of azithromycin in patients with Helicobacter pylori related gastritis 139
Clinical features of symptomatic uncomplicated diverticular disease: a multicenter Italian survey. 138
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 138
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2. 138
Gastroesophageal reflux symptoms among Italian university students: Epidemiology and dietary correlates using automatically recorded transactions 137
The general practitioner's approach to irritable bowel syndrome: from intention to practice 136
Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron 135
Intestinal pseudo-obstruction in inactive systemic lupus erythematosus: An unusual finding 134
Management of chronic constipation in general practice. 133
Radionuclide evaluation of the lower gastrointestinal tract 132
Abdominal ultrasound scan for the follow-up of pancreatic cystic lesions: could it play a role as a safe and cost-saving alternative to the routine MRI? 132
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome 131
Thrombocytopenic purpura: an unusual complication of eradication therapy for Helicobacter pylori 129
Hepatitis C virus chronic infection as a common cause of mixed cryoglobulinaemia and autoimmune liver disease 127
Dynamic MRI of the small bowel: usefulness of quantitative contrast-enhancement parameters and time-signal intensity curves for differentiating between active and inactive Crohn's disease. 127
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? 125
CT colonography: Project of High National Interest No. 2005062137 of the Italian Ministry of Education, University and Research (MIUR) RID A-2343-2011 124
Alginate controls heartburn in patients with erosive and nonerosive reflux disease. 123
Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy 122
Role of HCV infection in immune response to hepatitis B vaccination in chronic renal failure patients on hemodialysis. 122
Famotidine in the short-term treatment of duodenal ulcer and of concomitant peptic lesions : comparison with cimetidina 121
Barrett's esophagus results of a multicentric survey 120
Suspected laryngopharyngeal reflux evaluated with multichannel impedance and Ph-monitoring. How many are gerd patients? 120
Thyroid involvement in hepatitis C - Associated mixed cryoglobulinemia 120
The daily diary and the questionnaire are not equivalent for the evaluation of bowel habits 119
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 119
Can interferon-ribavirin effectively treat patients who did not respond to a first conventional therapy by interferon? 117
Could double-dose PPI therapy modify tissutal homeostasis in patients with barrett esophagus? 117
Giant cell arteritis of the leg in a patient with hepatitis C virus infection 116
Subthreshold psychiatric psychopathology in Functional gastrointestinal disorders: Can it be the bridge between gastroenterology and psychiatry? 116
Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease 114
Endoscopic ND:YAG laser therapy for villous adenomas of the right colon 114
Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: A comparative study 114
Long-term endoscopic surveillance of patients with Barrett’s esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study 113
The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment 113
Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole 113
Association between baseline impedance values and response proton pump inhibitors in patients with heartburn 113
Retrospective, observational, multicentre study on an Italian population affected by chronic hepatitis C who failed to clear HCV-RNA after the combined therapy (PEG-IFN and ribavirin): NADIR study 112
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 112
Alfa-fetoproteina e dimero-D nell'epatocarcinoma e nelle epatopatie croniche 111
Can interferon-ribavirin effectively treat patients who did not respond to a first conventional therapy by interferon? 111
CAGA STATUS DOES NOT INFLUENCE THE ERADICATION RATE OF HELICOBACTER PYLORI INFECTION BY A ONE WEEK TRIPLE THERAPY 111
Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: Common overlapping gastrointestinal disorders 111
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease 110
Exploring the genetics of irritable bowel syndrome: A GWA study in the general population and replication in multinational case-control cohorts 110
How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? 110
STUDIO DEGLI ACIDI BILIARI IN PAZIENTI CON COLESTASI E DRENAGGIO BILIARE PERCUTANEO ED IN PAZIENTI CON EPATOPATIA CRONICA NON COLESTATICA 109
White Paper of Italian Gastroenterology: Delivery of services for digestive diseases in Italy: Weaknesses and strengths 109
Consideration concerning the psyco-medical-social approach to alcohol-related problems. 108
COMMENT ON LETTER TO EDITOR 108
Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine 108
Endoscopic features of Barrett's esophagus 107
Assessment of the anti-reflux properties and therapeutic efficacy of Faringel in patients with mild to moderate GERD. 107
Manually calculated oesophageal bolus clearance time increases in parallel with reflux severity at impedance-pH monitoring 107
Neuroendocrine markers and psychological features in patients with irritable bowel syndrome 107
A seven day regimen with ranitidine bismuth citrate plus amoxycillin and clarithromycin is effective in eradicating H.Pylori and healing duodenal ulcer. 106
CagA status does not influence the eradication rate of Helicobacter pylori infection by a one-week triple therapy. 106
“PancPro” as a tool for selecting families eligible for pancreatic cancer screening: An Italian study of incident cases 106
Liver triglyceride accumulation after chronic ethanol administration: a possible protective role of metadoxina and ubiquinon 105
Progressive multifocal leukoencephalopathy in autoimmune disorders 105
Pros and Cons of the SeHCAT Test in Bile Acid Diarrhea: A More Appropriate Use of an Old Nuclear Medicine Technique 105
Bimodal rehabilitation has a long lasting efficacy in pelvic floor dyssynergia. 104
Esophageal testing: What we have so far 104
Barrett's esophagus in 2016: From pathophysiology to treatment 104
Association of chronic autoimmune active hepatitis and celiac disease: a case report. 103
Diagnostic accuracy of a saliva assay for antibodies to Helicobacter pylori in dyspeptic patients referred to first upper digestive endoscopy. 103
Alcohol and women: a study in high schools 103
Gastric emptying in myotonic dystrophic patients. 103
Chronic active hepatitis (CAH) due to hepatitis C virus (HCV): a double-blind, randomized trial of IFN ± colchicine. 102
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis 102
Irritable bowel syndrome and chronic constipation: Fact and fiction 101
Esophageal motility abnormalities in gastroesophageal reflux disease 101
Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure 101
Double-blind, randomized trial of IFN±colchicine in anti HCV-positive chronic active Hepatitis (CAH). 100
Dynamics of persistent TT virus infection, as estimated in patients treated with alpha interferon for concomitant hepatitis C 100
Assessment of bowel wall inflammation in Crohn's disease by a new quantitative ultrasound analysis as compared to vascularization in healthy volunteers bowel wall. 100
Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. 100
Le risque d'adenocarcinome sur oesophage de Barrett: resultat d'une etude multicentrique 99
Serum pepsinogen I and gastrin-17 levels are predictable of atrophic gastritis in patients with autoimmune thyroiditis and anti-gastric parietal cell autoantibodies. 99
Blood levels of TT virus following immune stimulation with influenza or hepatitis B vaccine 99
Nuclear translocation of GSTO is a progression marker in Barrett’s esophagus. 98
Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn 98
Assessment of proliferating cell nuclear antigen expression in dysplastic intestinal type Barrett's esophagus 96
Alcune considerazioni sull'approccio psico-medico-sociale ai problemi alcol-correlati XI Congresso S.I.A. 96
Pelvic floor dyssynergia and psychiatric disorders. Does the snake bite its tail? 96
Gastrointestinal manifestations in myotonic muscular dystrophy 96
Alginate controls heartburn in patients with erosive and nonerosive reflux disease 96
Totale 11.979
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.896
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.896
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.508 0 0 0 0 0 0 0 0 0 505 587 416
2019/20205.840 647 536 1.261 277 484 511 474 296 493 306 461 94
2020/20212.779 253 95 243 199 322 154 249 217 192 218 148 489
2021/20223.475 41 254 58 254 648 469 78 184 165 78 138 1.108
2022/20234.152 501 505 263 370 534 616 45 332 636 19 271 60
2023/20243.219 597 432 606 241 455 646 75 76 61 30 0 0
Totale 29.504